These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY. BLIX S Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542 [No Abstract] [Full Text] [Related]
12. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY]. DOUGLAS AS; MCNICOL GP Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145 [No Abstract] [Full Text] [Related]
13. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
14. STUDIES ON THE ADMINISTRATION OF STREPTOKINASE. A METHOD TO OBTAIN THROMBOLYTIC EFFECT WITHOUT EXCESSIVE FIBRINOGENOLYSIS. HELLE I; AAS K; GODAL HC Sangre (Barc); 1964; 38():167-74. PubMed ID: 14217607 [No Abstract] [Full Text] [Related]
15. FIBRINOLYTIC THERAPY IN MENINGITIS AND VENTRICULITIS. STEWART GT J Clin Pathol; 1964 May; 17(3):355-9. PubMed ID: 14159482 [No Abstract] [Full Text] [Related]
16. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN. HAWKEY CM; STAFFORD JL J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945 [TBL] [Abstract][Full Text] [Related]
17. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen. HOPKINS TF; MEITES J Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684 [No Abstract] [Full Text] [Related]
19. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA. ADAMIS DM; MANIATIS GM Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870 [No Abstract] [Full Text] [Related]
20. THE FIBRINOLYTIC SYSTEM DURING THE MENSTRUAL CYCLE. BELLER FK; GOEBELSMANN U; DOUGLAS GW; JOHNSON A Obstet Gynecol; 1964 Jan; 23():12-6. PubMed ID: 14110046 [No Abstract] [Full Text] [Related] [Next] [New Search]